McGowan T, McCue P, Sharma K
Division of Nephrology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Clin Lab Med. 2001 Mar;21(1):111-46.
Diabetic nephropathy is the leading cause of end-stage renal disease in the United States and the largest contributor to the total cost of diabetic care. In addition to the development of diabetic nephropathy and end-stage renal failure, diabetic patients with evidence of albuminuria have a much higher risk of developing myocardial infarctions, cerebrovascular accidents, severe progressive retinopathy, and neuropathy. This article characterizes the clinical and pathologic features of diabetic nephropathy and reviews the major pathogenetic theories that underlie the development of this dreaded complication of diabetes. Widespread screening for this condition and aggressive treatment of diabetic nephropathy at early stages of disease are critical to diminish the risk of costly late complications.
糖尿病肾病是美国终末期肾病的主要病因,也是糖尿病护理总成本的最大贡献因素。除了糖尿病肾病和终末期肾衰竭的发生外,有蛋白尿证据的糖尿病患者发生心肌梗死、脑血管意外、严重进行性视网膜病变和神经病变的风险要高得多。本文描述了糖尿病肾病的临床和病理特征,并综述了导致这种可怕的糖尿病并发症发生的主要发病机制理论。对这种疾病进行广泛筛查并在疾病早期积极治疗糖尿病肾病对于降低昂贵的晚期并发症风险至关重要。